Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rutuja D. Chougale"'
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 9, Iss 1, Pp 1-13 (2023)
Abstract Background Docetaxel (DTX) has been used to treat numerous types of cancers. Poor solubility, lower bioavailability, and serious side effects limit its use in cancer treatment. The objective of the present research work was to develop DTX-lo
Externí odkaz:
https://doaj.org/article/5f748a26d7ba4e93969fae08f13ea0cf
Autor:
Smita S. Patil, Rutuja D. Chougale, Arehalli S. Manjappa, John I. Disouza, Ashok A. Hajare, Kiran S. Patil
Publikováno v:
OpenNano, Vol 8, Iss , Pp 100079- (2022)
Docetaxel (DTX) has poor solubility, serious side effects, and multi-drug resistance (MDR) limiting its use in cancer treatment. Hence, the present study aimed to formulate and develop docetaxel mixed micelles (DTX MMs) for breast cancer treatment. D
Externí odkaz:
https://doaj.org/article/978d6dfe882c4f038806872a3c146211
Publikováno v:
Research Journal of Pharmacy and Technology. :4248-4252
Camptothecin is a potent anticancer agent. Numerous studies on camptothecin had been reported in the literature; here an effort is made to develop a new HPLC method for camptothecin estimation in pharmaceutical dosage forms that will be accurate, sim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0d7c3e289e35ce6c787b9cbee0f4c8f
https://doi.org/10.52711/0974-360x.2022.00714
https://doi.org/10.52711/0974-360x.2022.00714